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Leucinc-rich repcats (LRRs) are 22-28 amino acid-long sequence motifs found in a family of cytoplasmic, membrane and extracellular proteins, 
There is evidence that LRRs function in signal transduction, cellular adhesion and protein-protein interactions. Here we report unusual properties 
of a synthetic LRR peptide derived from the sequence ofthe Drosophila membrane receptor Toll. In neutral solution the peptide forms a gel revealed 
by electron microscopy to consist of extended filaments approximately 8 nm in thickness. As the gel forms, the circular dichroism spectrum of the 
peptide solution changes from one characteristic of random coil to one associated with/&sheet structures. Molecular modelling suggests that the 
peptides form an amphipathic structure with a predominantly apolar and charged surface. Based on these results, models for the gross structure 
of the peptide filaments and a possible molecular mechanism for cellular adhesion are proposed. 
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1. INTRODUCT-ION 
The product of the Drosophiiu Toll gene is a mem- 
brane receptor which functions during early embryo- 
genesis in the generation of dorso-ventral polarity (for 
a review see [l]). The primary structure of the Toll 
protein shows it to consist of extracellular, transmem- 
brane and cytoplasmic domains [2]. The C-terminal, 
cytoplasmic portion of the protein is homologous to 
that of the interleukin 1 receptor [3,4] while the extracel- 
lular domain is related to a family of membrane, ex- 
tracellular matrix and cytoplasmic proteins distin- 
guished by the presence of leucine-rich repeat sequences 
(LRRs). To date this family consists of yeast adenylate 
cyclase [S], the Drosophila adhesjon molecule chaoptin 
[G], mammalian proteoglycans PGi nnd PGll [7], the 
human lutropin-gonadotropin receptor [$I, human ri- 
bonuclease/angiogenin inhibitor [9] and the human pla- 
telet receptor glycoprotein lb (a@) complex (Gplb) 
[lO,l 11, Toll protein has additional sequences in com- 
mon with Gplb which may constitute ligand binding 
sites [12]. LRRs are 22-28 amino acids long and tend 
to occur within proteins in tandemly repeated blocks of 
between 1 and 26 copies. Apart from an N-terminal 
proline residue, a series of 6 conserved leucines and a 
single asparaginc, LRR sequences are highly divergent. 
In the case of adenylate cyclase, LRRs have a func- 
tional role, as site directed mutations located within 
LRRs cause disruption of the normal G-protein media- 
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ted signalling pathway [13]. The LRRs are also impli- 
cated in cell-cell interactions as chaoptin, which con- 
sists almost entirely of LRRs, and also Toll mediates 
cellular adhesion between apposed cell membranes 
[6,12]. In addition, the evidence suggests that the LRRs 
found in various proteoglycans and in ribonucJease/ 
angiogenin inbibitor are involved in specific protein- 
protein interactions [8,14J. 
At present little if anything is known about the three- 
dimensional structure that LRRs adopt although it has 
been proposed that they form amphipathic structures 
with hydrophobic surfaces capable of interacting with 
membranes [lS]. However, projection of LRRs into an 
a-helical structure does not result in such amphiphilicity 
and it is now clear that LRRs are not intrinsic to the 
membrane [6]. In this paper we describe the unusual 
properties of a peptide constituting a single LRR unit 
from the Dvoso$~rilu Toll receptor. It adopts a P-sheet 
structure in neutral solution and forms into extended 
filaments. These findings support the idea that LRRs 
mediate protein-protein interactions and cellular adhe- 
sion, 
2. EXPERIMENTAL 
The peptide NH,-1~ANLLTDMRNLSHLELRANIEEM~COOH 
(TL-LRR 1) corrcspondiny to residues 166-188 of the Drosu#ilu WC. 
lttrrngastcr Toll protcitl /2] was synrhcsised using solid phase Pmoc 
(fluorcnylmc~hoxycarbonyl) chemistry [ 171 on tl PharmacitiLKB Bio- 
lynx Autonlnted PcpGdc Synthcsiser. The prptidcchain was asscrnbled 
on ffz- %mo~nrrthiol~ise linked to 1.1 g of Ultrasyn A rain (subrtitu- 
tinn 70,8flmoI/g). Ftnoc-protected amino acids (0.5 mmol) used in the 
synthesis wcrc all 0.pcntafluorophcnyl (-OPfp) esters, coupled in hc 
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presence of I-hydroxybenzatriazole (HOBt) catalyst, with the excep- 
tion OF serine, threonine and arginine, which were present in the O- 
hydroxy-$_oxo-3.4.dihydro-1,2,3-benzotriazine (-ODhbt) ester Form. 
Side chain protection groups were r-butyl (Ser,Thr), r-butoxy (Asp, 
Clu), trityl (His) and 4-methoxy-2,3,6-trimethylbenzenesulphonyl, 
Mtr-, (A@. The synthesis was performed at room temperature using 
coupling times, in dimethyl Formamide, of 45-90 min; double cou- 
plings were performed at positions P,, L1, Tgr MB and SIz. Deprotection 
reactions were performed For 10 min in 20% piperidine in dime- 
thylformamide. 
The efficiency of chain cleavage From the resin and removal of the 
Mtr side-chain-protecting roup from the peptide by various cleavage 
reagents was monitored using analytical reverse phase HPLC (Brown- 
lee Aquapore RP300, 2.1 x 30 mm in 0.1% trifluoroacetic acid/aceto- 
nitrile). The best combination of reagents was determined as trifluro- 
acetic acid/thioanisole/ethanedithiol/anisole, 90:5:3:2 (by vol.) For 20 
h at room temperature. After removal of the acid by rotary evapora- 
tion, the crude peptide was precipitated with diethyl ether, washed in 
the same solvent and freeze-dried from a solution of 10% acetic acid. 
Purification OF the peptide was performed by reverse phase HPLC 
on a YMC-pack column (C,,), 25 mm x 25 cm, in 0.1% TFA with a 
gradient (30-43% over 37 min at 3 ml/min) of acetonitrile containing 
0.1% TFA. The sample was dissolved in 98-100% AR Formic acid and 
diluted out with water to 5% acid before application to the column. 
The principal component from each run was collected and Freeze- 
dried. The quality of the purified material was checked by(i) sequence 
analysis on a ABI 477A Pulsed Liquid Protein Sequencer; (ii) analyt- 
ical HPLC on a Rainin Dynamax C8 column, 4.6 x 250 mm in 0.1% 
TFA/acetonitrile; (iii) electrospray mass spectromctry in 1% acetic 
acid/50% methanol on a VG BioQ spectrometer; (iv) amino acid com- 
positional analysis, after acid hydrolysis (24 h) in 6 M I-ICI containing 
0.1% 2-mercaptoethanol at 1 IO”C, on an LKB 4400 Amino Acid 
Analyser using ninhydrin detection. 
Fig. 1. Purity of TL-LRRI monitored by reverse phase HPLC. A 
sample (approx. 1 nmol) of TL-LRRI was dissolved in water and 
applied to an analytical C8 column as described in section 2. The 
peptide was eluted with a gradient of O-64% acetonitrile containing 
0.1% TFA over 30 min at a flow of 0.7 ml/min (Hewlett Packard 
1090M liquid chromatograph). Detection was at 220 nm and diode 
array analysis suggested the major peak to be essentially homo- 
geneous. 
quence with 0.1% being 1 residue shorter. The predicted 
molecular mass of the peptide is 268 1.1 Da and, in close 
agreement with this prediction, analysis of the product 
using electrospray mass spectrometry indicates a mass 
of 2680.74 Da +0.74. No truncated or modified peptides 
were detected at the 2% level. 
3.2. Properties of TL-LRRI in solution 
Purified TL-LRRI peptide dissolves readily at neu- 
tral pH and is observed over a period of time to form 
a clear, viscous gel, with no evidence of a precipitate. 
The formation of this gelatinous olution can be moni- 
tored by circular dichroism spectroscopy. Initially, a 
strong negative CD band is observed at 200 nm (Fig. 
2A) but as the peptide solution becomes more viscous, 
the 200 nm band diminishes (Fig. 20-D) and finally is 
replaced by a spectrum displaying a positive, band at 
approximately 195 nm and a negative band at 2 16.5 nm, 
(Fig. 2E). This data shows that the gel formation by this 
peptide is accompanied by a change in structure from 
a disordered form (negative band at 200 nm) to a fi- 
sheet structure (see [I 71). The interactions giving rise to 
thefi-sheet structures appear to be intermolecular as the 
initial rate of formation of theb-sheet CD (as judged by 
the change in mean residue ellipticity at 200 nm) is 
concentration dependent (Fig. 3). When dissolved at an 
acidic PI-I (5.5) the peptide is significantly less soluble 
and does not form into a gel. The CD spectra show that 
at this pH it remains predominantly in a disordered 
conformation (result not shown). Titration pf the gel to 
acidic pH causes it to form a precipitate. 
The yield of the peptide was 18 flmol, representing asynthesis yield 
of 24%. 
2.2. Circulrrr dicitroimr spec~roscop,v 
The purified peptide was dissolved in 50 mM Tris-HCl, pH 8.2, and 
then diluted to 260 pg ml-’ in 10 mM sodium phosphate buffer p1-l 
7.8. Spectra of such peptide solutions were recorded between 190 and 
240 nm using a Jovin Yvon CD6 instrument and then subtracted From 
appropriate buffer blank spectra. The concentration of the peptide 
solutions was calculated by reference to amino acid analysis of the 
purified product and the CD is expressed as mean residue ellipticity 
(see I 171). 
2.3. Elecrron microscopy 
Samples of peptide solution were diluted in IO mM sodium phos- 
phate, pH 7.8, applied to EM grids and then stained For 1 min with __. 
a 0.5% solution of‘ uranyl acetate. The grids were examined with a 
Philips EM300 instrument. 
2.3. Moiearlor tnodelling 
Molecular models were generated using the program Macromodel 
D81. 
3. RESULTS 
3.1 s Purity of peptide TL-LLRI 
As described above, TL-LRRI pcptidc was purified 
by reverse phase high pressure liquid chromatography 
(HPLC) using a preparative Cl8 column, The product 
purified by this procedure lutes from an analytical C8 
HPLC column as a single peak with a minor shoulder 
(Fig. l), Protein secpencc analysis indicates that at least 
98% of this product is of the desired amino acid se- 
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In order to investigate the nature of the gel formed 
by TL-LRRl, samples were negatively stained and 
examined in the electron microscope. This reveals that 
the gel consists of extended filaments or fibres (Fig. 4). 
The thickness of the filaments is between 7 and 9 nm 
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Fig. 2. Circular diclwoism spcctre of pcptidc I’L-LRRI solutions. TL-LRR peptide wus dissolved at 2.G mgml”’ as described in section 2. Samples 
wcrc taken at various time points and the CD spectra mcasurcd. The spectra shown arc composed of 3 scans measured in OS nm stcpt for 0,s s 
each. (A) 0 min, (l3) 15 nlin, (C) 30 min, (D) 45 min, (E) 75 min. The positions of the CD band minima arc indicated in (A) and (E). 
and they are seen to extend to at lcast several micro- 
metres in length. This finding is in accord with the ex- 
petted propertics of a gel. 
3.4. Tltc EL-LRRl pq&ks in,8 ca$wtrtc~riott wtrkti he 
crtttptii~x~tliic itt ttcmre 
The structure of TL-LRRI filaments has been invcsti- 
gnted using the molecular modelling program Macro- 
model [ 181. Figure 5 shows the TL-LRRl peptide 
modelled 8s a paraM,&sheet structure. The model indi- 
cates that the side chains of the peptides will form a 
predominantly apolar surface including 4 of the 6 con- 
scrvcd hydrophobic residues and 3 hydrophilic surface 
with 6 of the 7 charged side chains in the pcptidc sc- 
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Mel. Elliplicity Although the LWWs of the chaoptin have been proposed 
(ZOOnm) to form into amphipathis /3 structures [6] the results 
(X 10-2) 0 reported above provide the first direct measurements of 
LRR secondary structure. Furthermore, it would ap- 
pear that j3 structure is common to LWW sequences as 
-100 
-200 
0 20 t (min) 4O 60 80 
Fig. 3. The initial rate of formation of/B steucture is concentration 
dependent. CD spectra were collected as in Fig. 2 for TL-LRRI 
peptide dissolved at either 2.6 mgml-’ (PO) or 5.2 mgml“ (t-*). The 
rate of formation /3 steucture is expressed as the change in the CD at 
200 nm, i.e. the disappearance of peptide in the random coil or dis- 
ordered form. 
quence. An antiparallel /I-structure would segregate the 
side chains in the same amphipathic fashion. It should 
be noted that although the CD spectra indicate a predo- 
minance of /3 sheet structure, it remains possible that 
other structures such as p bends and /3 bulges could be 
present and be important for the formation of the fila- 
ments. 
other peptides derived from Toll and chaoptin can also 
form /I sheets (NJ. Gay, unpublished results), /6]. The 
data presented here ‘do not determine whether TL- 
LRRl peptides form into anti-parallel or parallel p- 
sheet structures [ 171. I-lowever a molecular model of the 
peptides indicates that they would form an amphipathic 
structure with the conserved hydrophobic residues 
clustering on one surface. 
A basic subunit structure such as that illustrated in 
Fig. 5 leaves open several possibilities as to the gross 
composition of the filaments. Firstly, the peptide mole- 
sules could form into very long arrays of/&sheets. Such 
a structure accords with the observed thickness of the 
filaments as the length of the peptides in p conformation 
measured from the molecular model is 7.6 nm. Pleated 
sheets consisting of up to 10 strands have been observed 
in known structures [19]. A second possibility is that the 
filaments are stabilised by specific interactions between 
the amino acid sidechains. These could involve the for- 
mation of salt bridges between side chains on the char- 
Fig. 4. The gel formed by TL-LRlll consists of cxtcndcd filaments4 Sample.u were prepared as dcwibcd in cxpcrinrcntnl prercdurcx. l’hc scale 
bar itidiraks 100 m. 
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Fig. 5. Molecular model of TL-LRRl peptide in a parallel $-sheet conformation, The diagram is annotated in the three-letter code to indicate the 
composition of the two faces of the proposed structure. Residues conserved in all or most LRRs are in upper case letters and divergent amino 
acids in lower case. Side chains that carry a net charge at neutral pH are indicated + or -. 
ged surfaces of 2 peptide units and hydrophobic and 
Van der Waals interactions between side chains on the 
largely apolar surface. Again, such a structure would be 
in accord with the measured thickness of the filaments. 
A further possibility is that the peptide units are aligned 
along the axis of the filament in a staggered array, and 
again this might involve ionic; interactions between 
charged sidechains. However, such filaments would be 
expected to have a thickness not greater than about 2 
nm, significantly thinner than actually observed. In 
order to distinguish definitely between these and other 
possibilities, further structural studies are required. 
The finding that TL-LRKI forms intermolecular p- 
sheet structures supports the view that LRRs can parti- 
cipate in protein-protein interactions and homotypic 
celhtlar adhesion. It could be that LRRs expressed on 
the cell surface are initially of disordered structure and 
that interaction with similarly disordered LRRs on an 
adjacent cell causes the formation of an extended and 
stable intermolecular /I structure of the type formed by 
TL-LRRI . Such a mechanism could provide a molecu- 
lar basis for cellular adhesion mediated by LRRs, such 
as that observed with chaoptin. Furthermore, it has 
been proposed that the dominant ventralising proper- 
ties of truncated Toll molecules could be caused by their 
interaction with full length transmembranc molecules 
[4] and the closely related Gplb receptor complex may 
undergo ligand induced multimerisation [20]. It seems 
possible that such phenomena could also involve inter- 
actions between LRRs. 
The peculiar properties of TL-LRRI described here 
may find practical applications. The gel of TL-LRR 1 is 
analogous to that formed by polymerised acrylamide 
molecules and by uncrosslinked fibrin polymers. It 
seems possible that this pcptide might form the basis of 
r~ovcl separation media and may find use in affinity or 
bioscnsor applications. 
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